Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58

Table 2 Sites of local recurrence

Patients	Gender	Operation LAR/APR*	RII(+/-)	CEA(+/-)	Parabladder	Presacral	Colon	Perineal
1	M	LAR	+	16.4	+	+	-	-
2	F	LAR	+	25.4	+	-	-	-
3	M	APR	+	25.4	-	+	-	-
4	M	LAR	+	16.4	+	+	-	-
5	M	LAR	+	13.3	+	-	-	-
6	M	LAR	+	2.1	+	+	-	-
7	F	APR	+	23.9	-	+	+	-
9	M	LAR	+	8.2	+	-	-	-
10	M	LAR	+	6.0	-	+	-	-
11	M	APR	+	52.8	+	-	-	-
12	F	APR	+	9.0	-	+	-	-
13	M	LAR	+	50.0	-	-	-	-
14	F	LAR	+	52.0	+	-	-	-
15	F	LAR	+	500.0	+	+	-	-
16	M	LAR	+	33.9	+	-	-	+
17	F	LAR	+	317.7	+	-	-	-
18	M	APR	+	51.8	-	-	-	-
19	M	APR	+	68.7	+	-	-	-
20	F	LAR	+	17.9	+	+	-	+
21	M	APR	+	14.5	+	-	-	-
22	F	APR	+	27.5	-	-	-	-
23	M	APR	+	34.2	-	+	-	-
24	M	APR	+	6.8	-	+	-	+
25	F	LAR	+	8.9	+	+	-	-
26	M	LAR	+	1.0	+	-	-	-
27	F	APR	+	36.2	-	-	-	-
28	F	LAR	+	6.1	+	-	+	-
29	M	LAR	+	13.7	+	+	-	-
31	M	LAR	+	24.9	+	+	-	-
34	M	LAR	+	13.0	-	-	-	-
36	F	LAR	+	14.0	+	+	-	-